COAG: Hemab Therapeutics Holdings, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | New 13G stake | Novo Holdings A/S | 9.00% | SEC | |
| 2026-08-14 | New 13G stake | Avoro Capital Advisors LLC | 7.06% | SEC | |
| 2026-08-12 | New 13G stake | Capital International Investors | 7.70% | SEC | |
| 2026-08-07 | New 13G stake | Invus Public Equities, L.P. | 5.10% | SEC | |
| 2026-08-06 | New 13G stake | FMR LLC | 7.90% | SEC | |
| 2026-08-05 | New 13G stake | Sofinnova Crossover II SLP | 5.40% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.